Connect
MJA
MJA

Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5–9 May 2002

Saul B Freedman
Med J Aust 2002; 177 (9): . || doi: 10.5694/j.1326-5377.2002.tb04913.x
Published online: 4 November 2002

The 14th World Congress of Cardiology, held in Sydney 5–9 May 2002 (the first time ever in the antipodes), was a joint meeting with the 50th anniversary meeting of the Cardiac Society of Australia and New Zealand (CSANZ). The Congress is the principal meeting of the World Heart Federation, a body comprising all of the world's cardiac societies and heart foundations. Delegates came from 115 countries, and there was a total registration of just over 9000. More than 3000 abstracts were received from investigators in 82 countries.


  • Department of Cardiology, Concord Repatriation General Hospital, Concord, NSW.


Correspondence: ben@gmp.usyd.edu.au

  • 1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
  • 2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
  • 3. Duc, Cazabat, Lejoyeux M, et al. Severe depression is frequent but still untreated in patients with congestive heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 424B.
  • 4. Post F, Peetz D, Knoess P, et al. Brain natriuretic peptide for the evaluation of dyspneic patients in the emergency room. J Am Coll Cardiol 2002; 39(9) Suppl B: 193B.
  • 5. Aronson D, Horton DP, Burger AJ. Neseritide improves heart rate variability in patients with decompensated heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 403B.
  • 6. Allada CS, Keogh AM, Kotlyer E, et al. Carvedilol in elderly heart failure patients. J Am Coll Cardiol 2002; 39(9) Suppl B: 407B.
  • 7. Krum H, Coats AJS, Fowler MB, et al. The COPERNICUS Study Group. Effect of carvedilol on clinical status early following initiation of therapy in patients with severe chronic heart failure: results of the COPERNICUS Study. J Am Coll Cardiol 2002; 39(9) Suppl B: 404B.
  • 8. Abraham WT, Fisher W, Smith A, et al. Long term improvement in functional status, quality of life and exercise capacity in cardiac resynchronization therapy: the MIRACLE Trial experience. J Am Coll Cardiol 2002; 39(9) Suppl B: 465B.
  • 9. Atienza F, Ojeda S, Osca J, et al. Impact of an interactive education and home-monitoring program on hospital readmissions, survival and quality of life among patients with congestive heart failure. The PRICE Multicentre Study. J Am Coll Cardiol 2002; 39(9) Suppl B: 448B.
  • 10. Stewart S, Horowitz JD. Reduced morbidity, prolonged survival and lower health care costs: the long-term effects of post discharge, home-based intervention in chronic heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 449B.
  • 11. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-280.
  • 12. Smits PC, Maat L, Bolraap J, et al. Initial experience of percutaneous transendocardial delivery of autologous skeletal myoblasts for cellular myoplasty: a safety feasibility study. J Am Coll Cardiol 2002; 39(9) Suppl B; 191B.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.